Gabelli & Co Downgrades KV Pharmaceuticals (KV.A) to Hold
KV.A Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Gabelli & Co downgrades KV Pharmaceuticals (NYSE: KV.A) from Buy to Hold. Price target $2.
Gabelli analyst says, "Yesterday, during market hours, KV Pharmaceuticals announced that the company is indefinitely suspending distribution of all tablet products due to manufacturing and quality assurance concerns. This will impact the company's generic Ethex segment. Additionally, another lot of a specific product (hydromorphone HCl 2mg tablets) was recalled due to potential for being oversized...While we do not believe that Ethex is a lost cause, the lack of visibility gives us no assurance that the business is salvageable. Thus, we are assigning no value to that business and basing our PMV solely on the company's branded TherRx division."
K-V Pharmaceutical Company (KV) is a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets branded and generic/non-branded prescription pharmaceutical products.
Gabelli analyst says, "Yesterday, during market hours, KV Pharmaceuticals announced that the company is indefinitely suspending distribution of all tablet products due to manufacturing and quality assurance concerns. This will impact the company's generic Ethex segment. Additionally, another lot of a specific product (hydromorphone HCl 2mg tablets) was recalled due to potential for being oversized...While we do not believe that Ethex is a lost cause, the lack of visibility gives us no assurance that the business is salvageable. Thus, we are assigning no value to that business and basing our PMV solely on the company's branded TherRx division."
K-V Pharmaceutical Company (KV) is a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets branded and generic/non-branded prescription pharmaceutical products.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Brean Murray Carret & Co. Downgrades NetApp (NTAP) to Hold; Visibility Challenged
- Tudor Pickering Downgrades Petrobras (PBR) to Accumulate
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
